Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Assets Average (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Assets Average for 15 consecutive years, with $396.5 million as the latest value for Q4 2025.

  • Quarterly Assets Average rose 7.1% to $396.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $396.5 million through Dec 2025, up 7.1% year-over-year, with the annual reading at $373.9 million for FY2025, 9.02% down from the prior year.
  • Assets Average hit $396.5 million in Q4 2025 for Ironwood Pharmaceuticals, up from $369.5 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $1.1 billion in Q1 2023 to a low of $335.1 million in Q2 2025.
  • Historically, Assets Average has averaged $694.3 million across 5 years, with a median of $571.5 million in 2021.
  • Biggest five-year swings in Assets Average: skyrocketed 122.96% in 2021 and later tumbled 59.66% in 2024.
  • Year by year, Assets Average stood at $1.1 billion in 2021, then decreased by 2.97% to $1.1 billion in 2022, then crashed by 53.52% to $497.6 million in 2023, then decreased by 25.6% to $370.2 million in 2024, then increased by 7.1% to $396.5 million in 2025.
  • Business Quant data shows Assets Average for IRWD at $396.5 million in Q4 2025, $369.5 million in Q3 2025, and $335.1 million in Q2 2025.